Trial Profile
A Long-Term Clinical Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal Dysfunction
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Oct 2021
Price :
$35
*
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 05 Apr 2016 New trial record
- 24 Mar 2016 Pooled analysis (n=1031) of 4 trials - JapicCTI111507, JapicCTI111508, JapicCTI111509, and JapicCTI111543 were published in the Clinical Therapeutics.